KVUE - Kenvue Quarterly EPS earnings growth

Kenvue (KVUE) - corporate logo

Kenvue Inc. (KVUE) focuses on independent organic brand growth following its spin-off. The quarterly EPS trend visualizes this momentum, while the 8.10 metric confirms the current level. Success is based on global brand recognition and strict FDA oversight. Efficiency is further driven by inventory optimization and large-scale wholesale shipments to pharmacy chains.

Kenvue (KVUE) Year-over-year earnings per one share growth for the last 12 months: for the period 02/21/2024 - 11/14/2026

Analytical breakdowns for Kenvue Inc.

- share price and expert price forecast:
Stock Price Kenvue Corp|KVUE - Fair Value Consensus
- market capitalization statistics:
Market Capitalization Kenvue Corp|KVUE - Total Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Kenvue|KVUE - Accounting Value of Company|Market Value to Book Value Ratio kenvue.com|KVUE - Company Total Assets
- company liabilities and liquidity data:
Total Debt to Capital Kenvue Inc.|KVUE - Long-Term Liabilities to Capital|Short-Term Debt to Equity Kenvue Corp|KVUE - Company Aggregate Debt|Debt to Book Value Kenvue|KVUE - Company Long-Term Debt|Company Current Liabilities Kenvue|Quick Ratio kenvue.com
- earnings and market multiples details:
KVUE - Company Net Income|Future Profit Kenvue Inc.|KVUE - Company Value to Net Income|Forward P/E Multiple kenvue.com|KVUE - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Kenvue Inc|KVUE - Operating profit before amortization|Net earnings per share (EPS TTM) Kenvue|KVUE - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months kenvue.com|KVUE - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Kenvue Inc.
- sales revenue and business income indicators:
KVUE - Revenue and Sales Volume|Company Future Sales Volume Kenvue Corp|KVUE - Price-to-Revenue Ratio|Forward Price-to-Revenue Multiple Kenvue Health|KVUE - Sales Growth YoY (TTM)
Summary company analysis:Kenvue Corp, KVUE
Flagship merchandise of Kenvue Inc.

Steady demand for Tylenol and Band-Aid allows Kenvue Inc. (KVUE) to offset inflationary pressures by managing marketing expenses. This indicator measures the rate of change in earnings per share, reflecting the efficiency of shareholder value generation. An analysis of quarterly dynamics reveals hidden dips in profitability that remain unnoticed in annual reports. This helps investors adjust their capital allocation strategy in a timely manner. By tracking quarterly changes in earnings per share, one can objectively assess the resilience of the business model.

Direct competitors

HLN: Quarterly EPS earnings growth|Verona Pharma Corp - Year-over-year earnings per one share growth for the last 12 months|MENS (Jyong Biotech Limited) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months ligand.com LGND|Year-over-year earnings per share growth for the last twelve months Amneal (AMRX)|PRGO (Perrigo Company PLC) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ALVO (Alvotech S.A.)|Liquidia Technologies - Year-over-year earnings per share growth for the last twelve months|Galapagos Corp - Quarterly EPS earnings growth|ANIP (ANI Pharmaceuticals) - Year-over-year earnings per share growth for the last 12 months|MannKind Corp. (MNKD) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Corp) - Quarterly EPS earnings growth|SPRY: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth TBPH|Year-over-year net earnings per share change for the last twelve months Aquestive Therapeutics, Inc.|Year-over-year earnings per share growth for the last twelve months scPharmaceuticals Inc. SCPH|TECX: Year-over-year earnings per share growth for the last 12 months|TNXP - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months SXT Pharmaceuticals SXTC|EPRX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months bioharvest.com (BHST)|Year-over-year net earnings per share growth for the last 12 months EXOZ|ORMP: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Entera Bio Ltd. (ENTX)|HYFT (MindWalk Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ABVC (ABVC BioPharma, Inc)|Year-over-year earnings per one share growth for the last 12 months CPIX|QNTM - Year-over-year earnings per share growth for the last twelve months|FibroGen Corp (FGEN) - Year-over-year net earnings per share growth for the last 12 months|Telomir Pharmaceuticals Corp (TELO) - Year-over-year earnings per share growth for the last twelve months|Rani Therapeutics (RANI) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Synergy CHC Corp.|Earnings per share growth in annualized terms for the last twelve months rallybio.com RLYB|Quarterly EPS earnings growth LEXX|PULM: Year-over-year net earnings per share trend for the last twelve months|Pheton Holdings Ltd - Year-over-year net earnings per share growth for the last 12 months|APM - Year-over-year net earnings per share growth for the last 12 months|LYRA - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months IBO (Impact BioMedical)|TNF Pharmaceuticals Inc. (TNFA) - Year-over-year earnings per share growth for the last twelve months|cbdMD Corp - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months PRFX|Altamira Therapeutics (CYTO) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth LIPO|Quarterly EPS earnings growth optinose.com (OPTN)|Year-over-year earnings per share growth for the last twelve months Pieris Pharmaceuticals, Inc. PIRS|Procaps (PROC) - Earnings per share growth in annualized terms for the last twelve months|PTPI - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Qilian International Corp QLI|SLRN: Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months TFFP (tffpharma.com)